Literature DB >> 17451589

Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.

T van Meurs1, R van Doorn, G Kirtschig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451589     DOI: 10.1111/j.1524-4725.2007.33129.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  3 in total

Review 1.  Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review.

Authors:  Inga Neumann; R Patalay; M Kaushik; H Timlin; C Daniel
Journal:  Eye (Lond)       Date:  2022-07-14       Impact factor: 4.456

2.  Topical Imiquimod Treatment of Lentigo Maligna.

Authors:  F Ventura; J Rocha; J C Fernandes; F Pardal; C Brito
Journal:  Case Rep Dermatol       Date:  2009-10-31

3.  The effect of imiquimod on matrix metalloproteinases and tissue inhibitors of metalloproteinases in malignant melanoma cell invasion.

Authors:  Jin Young Jung; Hyun Sook Kim; Mi Ryung Roh; Hyo Jin Roh; Sang Yoon Lee; Kee Yang Chung
Journal:  Ann Dermatol       Date:  2014-06-12       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.